133 related articles for article (PubMed ID: 30961677)
1. Dermal peptide delivery using enhancer molecules and colloidal carrier systems - part V
Foerster A; Neubert RHH
Pharmazie; 2019 Mar; 74(3):136-141. PubMed ID: 30961677
[TBL] [Abstract][Full Text] [Related]
2. Dermal Peptide Delivery Using Enhancer Molecules and Colloidal Carrier Systems - Part IV: Search for an Alternative Model Membrane for Future ATR Permeation Studies Using PKEK as the Model Substance.
Foerster AC; Neubert RHH
Skin Pharmacol Physiol; 2019; 32(3):151-161. PubMed ID: 30943494
[TBL] [Abstract][Full Text] [Related]
3. Dermal peptide delivery using enhancer moleculs and colloidal carrier systems. Part II: Tetrapeptide PKEK.
Neubert RHH; Sommer E; Schölzel M; Tuchscherer B; Mrestani Y; Wohlrab J
Eur J Pharm Biopharm; 2018 Mar; 124():28-33. PubMed ID: 29247690
[TBL] [Abstract][Full Text] [Related]
4. Dermal peptide delivery using enhancer molecules and colloidal carrier systems. Part III: Tetrapeptide GEKG.
Sommer E; Neubert RHH; Mentel M; Tuchscherer B; Mrestani Y; Wohlrab J
Eur J Pharm Sci; 2018 Nov; 124():137-144. PubMed ID: 30165235
[TBL] [Abstract][Full Text] [Related]
5. Combination effect of penetration enhancers and propylene glycol on in vitro transdermal absorption of insulin.
Príborský J; Takayama K; Nagai T; Waitzová D; Elis J
Drug Des Deliv; 1987 Dec; 2(2):91-7. PubMed ID: 3334547
[TBL] [Abstract][Full Text] [Related]
6. Modulation of dihydroavenanthramide D release and skin penetration by 1,2-alkanediols.
Heuschkel S; Wohlrab J; Schmaus G; Neubert RH
Eur J Pharm Biopharm; 2008 Sep; 70(1):239-47. PubMed ID: 18514497
[TBL] [Abstract][Full Text] [Related]
7. Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin.
Babu RJ; Pandit JK
Drug Deliv; 2005; 12(3):165-9. PubMed ID: 16025846
[TBL] [Abstract][Full Text] [Related]
8. The effects of glycols on molecular mobility, structure, and permeability in stratum corneum.
Kis N; Gunnarsson M; Berkó S; Sparr E
J Control Release; 2022 Mar; 343():755-764. PubMed ID: 35150813
[TBL] [Abstract][Full Text] [Related]
9. Lateral diffusion of ibuprofen in human skin during permeation studies.
Schicksnus G; Müller-Goymann CC
Skin Pharmacol Physiol; 2004; 17(2):84-90. PubMed ID: 14976385
[TBL] [Abstract][Full Text] [Related]
10. Novel serine-based gemini surfactants as chemical permeation enhancers of local anesthetics: A comprehensive study on structure-activity relationships, molecular dynamics and dermal delivery.
Teixeira RS; Cova TF; Silva SM; Oliveira R; do Vale ML; Marques EF; Pais AA; Veiga FJ
Eur J Pharm Biopharm; 2015 Jun; 93():205-13. PubMed ID: 25748796
[TBL] [Abstract][Full Text] [Related]
11. Lysine-based surfactants as chemical permeation enhancers for dermal delivery of local anesthetics.
Teixeira RS; Cova TF; Silva SM; Oliveira R; Araújo MJ; Marques EF; Pais AA; Veiga FJ
Int J Pharm; 2014 Oct; 474(1-2):212-22. PubMed ID: 25108047
[TBL] [Abstract][Full Text] [Related]
12. Novel approach to improve permeation of ondansetron across shed snake skin as a model membrane.
Takahashi K; Rytting JH
J Pharm Pharmacol; 2001 Jun; 53(6):789-94. PubMed ID: 11428654
[TBL] [Abstract][Full Text] [Related]
13. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
Shah DK; Khandavilli S; Panchagnula R
Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
[TBL] [Abstract][Full Text] [Related]
14. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin.
Itoh T; Xia J; Magavi R; Nishihata T; Rytting JH
Pharm Res; 1990 Oct; 7(10):1042-7. PubMed ID: 2281034
[TBL] [Abstract][Full Text] [Related]
15. In vitro permeation study of hinokitiol: effects of vehicles and enhancers.
Joo HH; Kim JC; Lee HY
Drug Deliv; 2008 Jan; 15(1):19-22. PubMed ID: 18197519
[TBL] [Abstract][Full Text] [Related]
16. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
18. Reversible effects of permeation enhancers on human skin.
Kang L; Poh AL; Fan SK; Ho PC; Chan YW; Chan SY
Eur J Pharm Biopharm; 2007 Aug; 67(1):149-55. PubMed ID: 17270406
[TBL] [Abstract][Full Text] [Related]
19. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin.
Bond JR; Barry BW
J Invest Dermatol; 1988 Jun; 90(6):810-3. PubMed ID: 3373011
[TBL] [Abstract][Full Text] [Related]
20. [Modelling of pecutaneous drug permeation and investigation of penetration enhancer effect].
Csizmazia E; Berkó S; Maroda M; Szabóné RP; Csányi E
Acta Pharm Hung; 2012; 82(1):15-22. PubMed ID: 22570983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
